241 related articles for article (PubMed ID: 19339428)
1. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.
Nishiura JL; Neves RF; Eloi SR; Cintra SM; Ajzen SA; Heilberg IP
Clin J Am Soc Nephrol; 2009 Apr; 4(4):838-44. PubMed ID: 19339428
[TBL] [Abstract][Full Text] [Related]
2. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.
Grampsas SA; Chandhoke PS; Fan J; Glass MA; Townsend R; Johnson AM; Gabow P
Am J Kidney Dis; 2000 Jul; 36(1):53-7. PubMed ID: 10873872
[TBL] [Abstract][Full Text] [Related]
3. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients.
Levine E; Grantham JJ
AJR Am J Roentgenol; 1992 Jul; 159(1):77-81. PubMed ID: 1609726
[TBL] [Abstract][Full Text] [Related]
4. Renal stone disease in autosomal dominant polycystic kidney disease.
Torres VE; Wilson DM; Hattery RR; Segura JW
Am J Kidney Dis; 1993 Oct; 22(4):513-9. PubMed ID: 8213789
[TBL] [Abstract][Full Text] [Related]
5. Assessment of metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease: a cross-sectional study.
Chasan O; Mirioglu S; Artan AS; Gursu M; Kazancioglu R; Elcioglu OC
Clin Exp Nephrol; 2023 Nov; 27(11):912-918. PubMed ID: 37493903
[TBL] [Abstract][Full Text] [Related]
6. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
[TBL] [Abstract][Full Text] [Related]
7. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.
Ferraz RR; Fonseca JM; Germino GG; Onuchic LF; Heilberg IP
Urolithiasis; 2014 Aug; 42(4):301-7. PubMed ID: 24817661
[TBL] [Abstract][Full Text] [Related]
8. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
[TBL] [Abstract][Full Text] [Related]
9. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
10. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.
Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
J Nephrol; 2023 May; 36(4):999-1010. PubMed ID: 36753000
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
[TBL] [Abstract][Full Text] [Related]
12. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.
Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA
BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonographic renal volume measurements in early autosomal dominant polycystic disease: comparison with CT-scan renal volume calculations.
Hammoud S; Tissier AM; Elie C; Pousset M; Knebelman B; Joly D; Hélénon O; Correas JM
Diagn Interv Imaging; 2015 Jan; 96(1):65-71. PubMed ID: 25547671
[TBL] [Abstract][Full Text] [Related]
14. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
15. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
17. Autosomal dominant polycystic kidney disease (ADPKD) with multiple complications: Management challenges.
Djajapranata KM; Tjempakasari A
Narra J; 2024 Apr; 4(1):e584. PubMed ID: 38798842
[TBL] [Abstract][Full Text] [Related]
18. Abdominal sonographic study of autosomal dominant polycystic kidney disease.
Nicolau C; Torra R; Bianchi L; Vilana R; Gilabert R; Darnell A; Brú C
J Clin Ultrasound; 2000; 28(6):277-82. PubMed ID: 10867665
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
[TBL] [Abstract][Full Text] [Related]
20. Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study.
McGovern AP; Jones S; van Vlymen J; Saggar AK; Sandford R; de Lusignan S
BMC Nephrol; 2014 Nov; 15():182. PubMed ID: 25412767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
